Login +0086-27-65522453 [email protected]

Vorapaxar(free base) Catalog No : 16070916

Chemical Information

Product NameVorapaxar(free base)
Iupac Chemical NameEthyl N-[(3R,3aS,4S,4aR,7R,8aR,9aR)-4-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f]isobenzofuran-7-yl]carbamate 
SynonymsSCH530348;SCH 530348, 
Molecular FormulaC29H35FN2O8S 
Molecular Weight590.6634 
SmileFC=1C=C(C=CC1)C=1C=CC(=NC1)/C=C/[[email protected]]1[[email protected]]2[[email protected]](C[[email protected]]3C(O[[email protected]@H]([[email protected]@H]13)C)=O)C[[email protected]@H](CC2)NC(OCC)=O
InChiKeyZBGXUVOIWDMMJE-QHNZEKIYSA-N
InChiInChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1
Cas618385-01-6

Technical Data

AppearanceSolid powder 
Purity98% by HPLC 
SolubilitySoluble in DMSO 
Storage-20 ºC for 3 years 
Shipping ConditionShipped under ambient temperature 
Quality control

Description

Vorapaxar, also known as SCH 530348, is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine. Discovered by Schering-Plough and currently being developed by Merck & Co., it is an experimental pharmaceutical treatment for acute coronary syndrome chest pain caused by coronary artery disease. On May 05, 2014, vorapaxar obtained FDA approval. 

Chemical Structure

16070916 - Vorapaxar(free base) | CAS 618385-01-6

Package

SizePrice
Login to get price

Quick Order

Change

Contact Us